Guggenheim Capital’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-47,120
| Closed | -$1.54M | – | 2105 |
|
|
2022
Q2 | $1.54M | Buy |
+47,120
| New | +$1.49M | 0.01% | 1015 |
|
|
2017
Q4 | – | Sell |
-9,736
| Closed | -$366K | – | 2842 |
|
|
2017
Q3 | $366K | Buy |
9,736
+617
| +7% | +$21.8K | ﹤0.01% | 2489 |
|
|
2017
Q2 | $340K | Buy |
9,119
+2,933
| +47% | +$106K | ﹤0.01% | 2519 |
|
|
2017
Q1 | $243K | Buy |
+6,186
| New | +$232K | ﹤0.01% | 2589 |
|
|
2016
Q4 | – | Sell |
-31,568
| Closed | -$1.24M | – | 3009 |
|
|
2016
Q3 | $1.24M | Sell |
31,568
-4,142
| -12% | -$165K | ﹤0.01% | 1956 |
|
|
2016
Q2 | $1.35M | Sell |
35,710
-1,369
| -4% | -$45.8K | ﹤0.01% | 1831 |
|
|
2016
Q1 | $1.43M | Sell |
37,079
-8,069
| -18% | -$300K | ﹤0.01% | 1811 |
|
|
2015
Q4 | $2.17M | Sell |
45,148
-24,579
| -35% | -$1.14M | 0.01% | 1561 |
|
|
2015
Q3 | $2.75M | Buy |
69,727
+746
| +1% | +$31.7K | 0.01% | 1375 |
|
|
2015
Q2 | $2.94M | Buy |
68,981
+18,133
| +36% | +$723K | 0.01% | 1468 |
|
|
2015
Q1 | $2.01M | Buy |
50,848
+10,959
| +27% | +$404K | ﹤0.01% | 1774 |
|
|
2014
Q4 | $1.44M | Sell |
39,889
-8,942
| -18% | -$300K | ﹤0.01% | 1986 |
|
|
2014
Q3 | $1.44M | Sell |
48,831
-5,250
| -10% | -$145K | ﹤0.01% | 1998 |
|
|
2014
Q2 | $1.36M | Sell |
54,081
-6,994
| -11% | -$173K | ﹤0.01% | 2090 |
|
|
2014
Q1 | $1.58M | Sell |
61,075
-25,644
| -30% | -$646K | ﹤0.01% | 1950 |
|
|
2013
Q4 | $1.95M | Buy |
+86,719
| New | +$1.67M | 0.01% | 1814 |
|
Other funds holding NTUS
Guggenheim Capital's NTUS Position: Q3 2022 in Review
Guggenheim Capital sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 47,120 shares — an estimated $1.54M sold.
Guggenheim Capital first reported a position in NTUS in Q4 2013 and held it in 16 quarters. The position peaked at $2.94M in Q2 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Guggenheim Capital reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Guggenheim Capital sold 47,120 Natus Medical Inc shares in Q3 2022, an estimated $1.54M.
- Guggenheim Capital first reported a position in Natus Medical Inc in Q4 2013 and held it in 16 quarters.
- Guggenheim Capital's Natus Medical Inc position peaked at $2.94M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.